The results indicated that elevated HLA-E levels (IRS ≥ 6) are associated with lymph node metastasis in ESCC and are predictive of both the cumulative incidence of recurrence (CIR) and tumor-related death (CID). This evidence concerns the gene HLA-E and metastatic malignant neoplasm in the lymph nodes.